Semin Neurol 2014; 34(05): 534-541
DOI: 10.1055/s-0034-1396007
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Amyotrophic Lateral Sclerosis

Rabia Malik
1   Department of Neurology, UCSF Medical Center, San Francisco, California
,
Andrew Lui
2   Department of Physical Therapy and Rehabilitation Science, UCSF Medical Center, San Francisco, California
,
Catherine Lomen-Hoerth
1   Department of Neurology, UCSF Medical Center, San Francisco, California
› Author Affiliations
Further Information

Publication History

Publication Date:
17 December 2014 (online)

Preview

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting 20,000 to 30,000 people in the United States. The mainstay of care of patients affected by this disease is supportive and given the multifaceted nature of their needs is provided most efficiently through multidisciplinary clinics that have shown to prolong survival and improve quality of life. The authors discuss in detail evidence-based management of individuals affected by this condition.